Matthew C Winter

Summary

Affiliation: University of Sheffield
Country: UK

Publications

  1. ncbi Exploring the anti-tumour activity of bisphosphonates in early breast cancer
    M C Winter
    Academic Unit of Clinical Oncology, Section for Cancer, Cancer Research Centre, University of Sheffield, Weston Park Hospital, Sheffield S10 2SJ, UK
    Cancer Treat Rev 34:453-75. 2008
  2. ncbi Ten years of rituximab in NHL
    Matthew C Winter
    Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, University of Sheffield, UK
    Expert Opin Drug Saf 8:223-35. 2009
  3. ncbi Bisphosphonates in breast cancer: teaching an old dog new tricks
    Matthew C Winter
    Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, UK to Top
    Curr Opin Oncol 21:499-506. 2009

Detail Information

Publications3

  1. ncbi Exploring the anti-tumour activity of bisphosphonates in early breast cancer
    M C Winter
    Academic Unit of Clinical Oncology, Section for Cancer, Cancer Research Centre, University of Sheffield, Weston Park Hospital, Sheffield S10 2SJ, UK
    Cancer Treat Rev 34:453-75. 2008
    ....
  2. ncbi Ten years of rituximab in NHL
    Matthew C Winter
    Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, University of Sheffield, UK
    Expert Opin Drug Saf 8:223-35. 2009
    ..Rituximab, a chimeric mouse/human monoclonal antibody targeting the pan-B-cell antigenic marker CD20, was the first monoclonal antibody licensed for use in the treatment of cancer...
  3. ncbi Bisphosphonates in breast cancer: teaching an old dog new tricks
    Matthew C Winter
    Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, UK to Top
    Curr Opin Oncol 21:499-506. 2009
    ..However, recent data suggest that bisphosphonate use in breast cancer may provide more than just supportive care and modify the course of the disease by disrupting the metastatic process...